• ADMA Biologics' (ADMA) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

    المصدر: Buzz FX / 04 مارس 2025 10:36:16   America/New_York


    ADMA Biologics' (ADMA) "Overweight" Rating Reaffirmed at Cantor Fitzgerald Written by MarketBeat March 4, 2025 Share Link copied to clipboard. ADMA Biologics ( NASDAQ:ADMA - Get Free Report ) 's stock had its "overweight" rating reiterated
    Read more...
شارك على،